Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2006 048 687.1 |
96 | EP file number | EAKZ | 06 77 6678.2 |
86 | WO file number | WAKZ | PCT/EP2006/007839 |
97 | EP publication number | EPN | 1912625 |
87 | WO publication number | WPN | 2007017248 |
54 | Designation/title | TI | ITRACONAZOL-ZUSAMMENSETZUNGEN MIT VERBESSERTER BIOVERFÜGBARKEIT |
51 | IPC main class | ICM (ICMV) | A61K 9/14 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/496 (2006.01) |
22 | DE application date | DAT | Aug 8, 2006 |
96 | EP application date | EAT | Aug 8, 2006 |
86 | WO application date | WAT | Aug 8, 2006 |
43 | Date of first publication | OT | Feb 15, 2007 |
| Date of publication of grant | PET | Apr 13, 2016 |
71/73 | Applicant/owner | INH | AbbVie Deutschland GmbH & Co. KG, 65205 Wiesbaden, DE; Stiefel Laboratories, Inc., Wilmington, DE, US |
72 | Inventor | IN | BERNDL, Gunther, 67273 Herxheim am Berg, DE; DEGENHARDT, Matthias, 67061 Ludwigshafen-Ruchheim, DE; MÄGERLEIN, Markus, 68199 Mannheim, DE; DISPERSYN, Gerrit, Princeton, NJ 08540, US |
74 | Representative | VTR | Reitstötter Kinzebach, 81679 München, DE |
| Address for service | | Reitstötter Kinzebach, 81633 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 595816 P Aug 8, 2005
|
| Due date | FT FG | Aug 31, 2025 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001912625 Searchable text:
EP000001912625 Original document:
EP000001912625B1 Searchable text:
EP000001912625B1 Original document:
WO002007017248 Searchable text:
WO002007017248 |
43 | Date of first publication | EVT | Feb 15, 2007 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 11, 2024 (Show all update days)(Hide all update days)- Sep 11, 2024
- St.36: changed (technical change)
- Jul 13, 2024; Jan 25, 2024; Dec 15, 2023; Jul 14, 2023; Jun 28, 2022; Jul 21, 2021; Jul 16, 2020; Aug 21, 2019; Aug 3, 2019; Oct 29, 2018; Jul 28, 2018; Sep 2, 2017; Apr 27, 2017; Mar 23, 2017; Feb 16, 2017; Sep 16, 2016; Apr 30, 2016; Apr 20, 2016; Apr 14, 2016; May 9, 2015; Feb 1, 2013
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Dec 14, 2023 |
| Issue number | HN | 4 |
| Year | PJ | 2024 |
| Publication date | VT | Jan 25, 2024 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | AbbVie Deutschland GmbH & Co. KG, 65205 Wiesbaden, DE; Stiefel Laboratories, Inc., Wilmington, DE, US |
71/73 | Previous applicant/owner | INHF | AbbVie Deutschland GmbH & Co. KG, 65205 Wiesbaden, DE, Barrier Therapeutics, Inc., Princeton, N.J., US |
| Date of update of the procedure | REGT | Jan 25, 2024 |